Australia markets closed

Ovid Therapeutics Inc. (1OT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.9800-0.0400 (-1.32%)
At close: 08:02AM CEST
Full screen
Previous close3.0200
Open2.9800
Bid2.8800 x 0
Ask2.9400 x 0
Day's range2.9800 - 2.9800
52-week range2.4600 - 3.6800
Volume1,000
Avg. volume0
Market cap211.415M
Beta (5Y monthly)0.69
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results

    Takeda has completed two Phase 3 trials studying soticlestat as a treatment for Lennox-Gastaut syndrome and Dravet syndrome; topline data are anticipated in Takeda's H1 2024 fiscal yearA Phase 1, double-blind, multiple-ascending dose trial evaluating OV888 (GV101) is complete; topline safety data are expected in H1 2024Ovid expects to initiate a Phase 2 clinical program studying OV888 (GV101) in cerebral cavernous malformations in H2 2024Cash, cash equivalents and marketable securities were $90.

  • GlobeNewswire

    Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

    NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference on Monday, May 20, 2024, at 3:00 p.m. ET. A live webcast of the fireside chat can be accessed through the Even

  • GlobeNewswire

    Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

    NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by rare epilepsies and brain conditions, today announced that management will participate in a virtual presentation at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 9:30 a.m. ET. A live webcast of the Needham presentation can be accessed through the Events & Presentations section of